Treatment of short bowel syndrome patients with colon-in-continuity

  • US 7,847,061 B2
  • Filed: 11/01/2005
  • Issued: 12/07/2010
  • Est. Priority Date: 11/01/2004
  • Status: Active Grant
First Claim
Patent Images

1. A method for enhancing intestinal absorption in a patient with short bowel syndrome presenting with colon in continuity with remnant small intestine, comprising the steps of selecting for treatment a short bowel syndrome patient presenting with colon in continuity with remnant small intestine, and treating said patient with a GLP-2 receptor agonist using a dosing regimen effective to enhance intestinal absorption by said patient, wherein said GLP-2 receptor agonist is selected from the group consisting of a GLP-2 peptide, a GLP-2 analog, a derivatized GLP-2 peptide or a derivatized GLP-2 analog.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×